Alkermes PLC (ALKS)
24.69
+0.25
(+1.02%)
USD |
NASDAQ |
Apr 26, 16:00
24.69
0.00 (0.00%)
After-Hours: 20:00
Alkermes Enterprise Value: 3.601B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 3.601B |
| April 24, 2024 | 3.636B |
| April 23, 2024 | 3.571B |
| April 22, 2024 | 3.539B |
| April 19, 2024 | 3.502B |
| April 18, 2024 | 3.487B |
| April 17, 2024 | 3.529B |
| April 16, 2024 | 3.489B |
| April 15, 2024 | 3.530B |
| April 12, 2024 | 3.597B |
| April 11, 2024 | 3.692B |
| April 10, 2024 | 3.885B |
| April 09, 2024 | 3.983B |
| April 08, 2024 | 3.850B |
| April 05, 2024 | 3.881B |
| April 04, 2024 | 3.829B |
| April 03, 2024 | 3.916B |
| April 02, 2024 | 3.990B |
| April 01, 2024 | 4.068B |
| March 28, 2024 | 4.040B |
| March 27, 2024 | 4.070B |
| March 26, 2024 | 3.992B |
| March 25, 2024 | 4.080B |
| March 22, 2024 | 4.077B |
| March 21, 2024 | 4.023B |
| Date | Value |
|---|---|
| March 20, 2024 | 4.147B |
| March 19, 2024 | 4.145B |
| March 18, 2024 | 4.117B |
| March 15, 2024 | 4.321B |
| March 14, 2024 | 4.342B |
| March 13, 2024 | 4.327B |
| March 12, 2024 | 4.274B |
| March 11, 2024 | 4.296B |
| March 08, 2024 | 4.404B |
| March 07, 2024 | 4.438B |
| March 06, 2024 | 4.352B |
| March 05, 2024 | 4.489B |
| March 04, 2024 | 4.516B |
| March 01, 2024 | 4.570B |
| February 29, 2024 | 4.478B |
| February 28, 2024 | 4.496B |
| February 27, 2024 | 4.479B |
| February 26, 2024 | 4.536B |
| February 23, 2024 | 4.458B |
| February 22, 2024 | 4.347B |
| February 21, 2024 | 4.393B |
| February 20, 2024 | 4.595B |
| February 16, 2024 | 4.894B |
| February 15, 2024 | 4.957B |
| February 14, 2024 | 4.194B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.812B
Minimum
Mar 18 2020
5.279B
Maximum
Jun 22 2023
3.564B
Average
3.574B
Median
Enterprise Value Benchmarks
| Endo International PLC | -777.78M |
| Jazz Pharmaceuticals PLC | 10.78B |
| Medtronic PLC | 122.24B |
| Perrigo Co PLC | 7.560B |
| Iterum Therapeutics PLC | 20.82M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 112.78M |
| Revenue (Quarterly) | 377.48M |
| Total Expenses (Quarterly) | 198.90M |
| EPS Diluted (Quarterly) | 0.66 |
| Gross Profit Margin (Quarterly) | 81.43% |
| Profit Margin (Quarterly) | 29.88% |
| Earnings Yield | 8.38% |
| Operating Earnings Yield | 9.93% |
| Normalized Earnings Yield | 9.518 |